MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Does age at onset of Parkinson’s disease affect the development of dementia?

    P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)

    Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…
  • MDS Virtual Congress 2020

    A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study

    A. Jha, S. D'costa, W. White, M. Chapp, D. Kanhai (Managua, Nicaragua)

    Objective: The current study aims to compare and evaluate the fluctuating qualitative dermatoglyphic trait, Furuhata’s and Dankmeijer’s index as a risk marker in Diabetes and…
  • MDS Virtual Congress 2020

    Identification of Parkinson’s disease predisposition genes in high-risk pedigrees

    P. Moretti, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, UT, USA)

    Objective: To identify families with an increased risk of Parkinson’s disease (PD) and the gene variants associated with such increased disease risk studying large multi-generation…
  • MDS Virtual Congress 2020

    Alpha-synuclein and Amyloid beta peptide 1-42 in Parkinson’s disease and parkinsonian plus syndrome cohorts

    G. Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: To evaluate the serum levels of α-synuclein (α-syn) and Amyloid β 1-42 (Aβ1-42) in the patients of Parkinson’s disease (PD), progressive supranuclear palsy (PSP)…
  • MDS Virtual Congress 2020

    Body weight and brainstem raphe echogenicity in patients with Parkinson’s disease

    J.S Baik, H.I Ma (Seoul, Republic of Korea)

    Objective: We aimed to investigate and compare of body weight between normal and abnormal BR echogenicity in patients with PD. Background: Weight loss is frequent…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • MDS Virtual Congress 2020

    Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study

    A. Roux, F. Durif, A. Marques, J. Bonny, B. Pereira (Clermont Ferrand, France)

    Objective: To study morphometric and structural connectivity changes in the mesocorticolimbic pathway associated with the occurrence of impulse control disorders in Parkinson's disease. Background: Impulse…
  • MDS Virtual Congress 2020

    Differentiating Parkinson’s disease dementia and mild cognitive impairment from idiopathic Parkinson’s disease using machine learning approach

    A. Bhattacharya, N. Kamble, A. S, V. N, A. Stezin, S. Hegde, A. J, R. Yadav, P. Pal (Bengaluru, India)

    Objective: This paper aims at creating a computer-based diagnosis tool which can predict the classification of MCI and dementia in patients of Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Impulse Control Behaviours in People with Parkinson’s Disease: Findings from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

    A. Antonini, E. Tolosa, J. Ferreira, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Padova, Italy)

    Objective: Presence of impulse control behaviour (ICB) was assessed in PRISM, a European survey of people with Parkinson’s disease (PwP) and their care-partners. Background: Impulse…
  • MDS Virtual Congress 2020

    Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease

    I. Lin, B. Edison, S. Mantri, M. Daeschler, K. Kopil, C. Marras, L. Chahine (Pittsburgh, PA, USA)

    Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley